A limited-sampling method for evaluation of the area under the curve of ultrafilterable carboplatin in children

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 3, 1998, Pages 250-254

  Doz, F ^a   Urien, S ^b   Chatelut, E ^c   Michon, J ^a   Rubie, H ^d   Zucker, J M ^a   Canal, P ^c   Bastian, G ^e  

^a INSTITUT CURIE   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d CHU PURPAN   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

AUC; Bayesian approach; Limited sampling method; Ultrafilterable carboplatin

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BAYES THEOREM; BODY SURFACE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; MALE; PREDICTION; PRIORITY JOURNAL; SAMPLING; SOLID TUMOR; ULTRAFILTRATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; SAMPLING STUDIES;

EID: 0031871169     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050813     Document Type: Article

References (24)

1. Calvert AH, Newell DR, Gumbrell LA, O'Reilley S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7: 1748
2. Doz F, Pinkerton R (1994) What is the place of carboplatin in paediatric oncology? Eur J Cancer 30A: 194
3. 2 in children. Med Pediatr Oncol 18: 459
4. Doz F, Neuenschwander S, Plantaz D, Courbon B, Gentet J-C, Bouffet E, Mosseri V, Vannier J-P, Méchinaud F, Desjardins L, Vielh P, Zucker J-M (1995) Etoposide and carboplatin in extraocular retinoblastoma: a study by the Soçiété Francaise d'Oncologie Pédiatrique. J Clin Oncol 13: 902
5. Egorin MJ, Echo DA van, Tipping SJ, Olman EA, Whitacre MY, Thompson BN, Aisner J (1984) Pharmacokinetics and dose reduction of cis-diammine(1,1-cyclobutane-dicarboxylatoplatinum) in patients with impaired renal function. Cancer Res 44: 5432
6. Frappaz D, Michon J, Hartman O, Bouffet E, Lejard O, Rubie H, Gentet JC, Chastagner P, Sariban E, Brugière L, Zucker JM, Lemerle J, Philip T (1992) Eloposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study. J Clin Oncol 10: 1592
7. Garaventa A, Hartmann O, Bernard JL, Zucker JM, Pardo N, Casterl Y, Dallorso S, Abelbost Z, Ladenstein R, Chauven F, Philip T (1994) Autologous bone marrow transplanation for pediatric Wilms' tumor: the experience of the European bone marrow transplantation registry. Med Pediatr Oncol 22: 11
8. Gentet JC, Doz F, Bouffet E, Plantaz D, Roché H, Tron P, Kalifa C, Bernard JL, Zucker JM, Raybaud C (1994) Carboplatin and VP16 in medulloblastoma: a phase II study. Med Pediatr Oncol 23: 422
9. Horwich A, Dearnaley DP, Nicholls J, Jay G, Mason M, Harland S, Pekham MJ, Hendry WF (1992) Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular non-seminomatous germ cell tumors. J Clin Oncol 9: 62
10. Le Roy AF, Wehling ML, Sponseller HL (1977) Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 18: 184-191
11. Madden T, Sunderland M, Santana VM, Rodman JH (1992) The pharmacokinetics of high-dose carboplatin in pediatric patients with cancer. Clin Pharmacol Ther 51: 701
12. Marina NM, Rodman JH, Shema SJ, Bowman LC, Douglas E, Furman W, Santana VM, Hudson M, Wilimas J, Meyer W, Madden T, Pratt C (1993) Phase I study of escalated doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. J Clin Oncol 11: 554
13. Marina NM, Rodman JH, Murry DJ, Shema JS, Bowman LC, Jones DP, Furman W, Meyer WH, Pratt CB (1994) Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors. J Natl Cancer Inst 86: 544-548
14. Murry DJ, Sundlund JT, Stricklin LM, Rodman JH (1993) Pharmacokinetics and acute renal effects of continuously infused carboplatin. Clin Pharmacol Ther 54: 374
15. Namouni F, Doz F, Tanguy ML, Michon J, Pacquement H, Bouffet E, Gentet JC, Plantaz D, Lutz X, Vannier JP, Zucker JM (1995) High dose chemotherapy with carboplatin. etoposide and cyclophosphamide with hematopoietic stem cell rescue in high risk retinoblastoma (abstract). Med Pediatr Oncol 25: 245
16. Newell DR, Pearson ADJ, Balmanno K, Price L, Wyllie RA, Keir M, Calvert AH, Lewis IJ, Pinkerton CR, Stevens MCG (1993) Carboplatin pharmacokinetics in children: the development of a paediatric dosage formula. J Clin Oncol 11: 2314
17. Pein F, Pinkerton R, Tournade MF, Brunat-Mentigny M, Levin G, Marguerite G, Rubie H, Sommelet D, Thyss A, Zucker JM (1993) Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group. J Clin Oncol 11: 1478
18. Peng B, Boddy AV, Cole M, Pearson ADJ, Chatelut E, Rubie H, Newell DR (1995) Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients. Eur J Cancer 31A: 1804-1810
19. Philip T, Ladenstein R, Zucker JM, Pinkerton R, Bouffet E, Louis D, Sieger W, Bernard JL, Frappaz D, Coze C, Wyss M, Beck D, Souillet G, Michon J, Philip I, Chauvin F, Favrol M, Biron P (1993) Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE 2 study. Br J Cancer 67: 119-127
20. Riccardi R, Riccardi A, Lasorella A, Di Rocco C, Carelli G, Tornesello A, Servidei T, Iavarone A, Mastrangelo R (1994) Clinical pharmacokinetics of carboplatin in children. Cancer Chemother Pharmacol 33: 477
21. Sheiner LB, Beal SL (1982) Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. J Pharm Sci 71: 1344
22. Sorensen BT, Strömgen A, Jakobson P, Nielsen JT, Andersen LS, Jakobsen A (1991) Dose-toxicity relationship of carboplatin in combination with cyclophosphamide in ovarian cancer patients. Cancer Chemother Pharmacol 28: 397
23. Sorensen BT, Strömgren A, Jakobsen P, Jakobsen A (1993) A limited sampling method for estimation of the carboplatin area under the curve. Cancer Chemother Pharmacol 31: 323
24. Urien S (1995) MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes. Pharm Res 12: 1225-1230